High SHIP2 Expression Indicates Poor Survival in Colorectal Cancer

Table 1

The relationship between SHIP2 expression and clinical attributes of 102 CRC patients.

Groups	Number	SHIP2			value
		+	%
Gender
Male	63	31	49.2	0.04	0.839
Female	39	20	51.3
Age (years)
≥60	68	34	50.0	0.00	1.000
<60	34	17	50.0
Tumor size (cm)
≥5	44	21	47.7	0.16	0.689
<5	58	30	51.7
Tumor location
Colon	87	43	49.4	1.10	0.576
Rectum	11	5	45.5
Ileocecal junction	4	3	75.0
Histological type
Adenocarcinoma	99	48	48.5	3.09	0.079
Nonadenocarcinoma	3	3	100.0
Tumor differentiation
Well	4	1	25.0	1.32	0.518
Moderately	82	44	53.7
Poorly	7	4	57.1
Insufficient data	9	2
Serum CEA level (ng/mL)
≥15	11	6	54.5	0.30	0.581
<15	59	25	42.4
Insufficient data	32	20
Lymph node metastasis
Positive	34	22	64.7	4.41	0.036^*
Negative	68	29	42.6
Distant metastasis
Positive	19	17	89.5	14.55	0.001^*
Negative	83	34	41.0
TNM stage
Stages I, II	63	27	42.9	3.36	0.067
Stages III, IV	39	24	61.5
Overall survival
Survival	61	24	39.3	6.89	0.009^*
Death	41	27	65.9

.